TPA
AMGN icon

Trivium Point Advisory’s Amgen AMGN Stock Holding History

Trivium Point Advisory’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.01M Sell
2,876
-583
-17% -$208K 0.18% 129
2025
Q4 		$1.13M Sell
3,459
-361
-9% -$115K 0.11% 167
2025
Q3 		$1.08M Buy
3,820
+223
+6% +$64.7K 0.11% 171
2025
Q2 		$1M Sell
3,597
-11,007
-75% -$3.12M 0.11% 172
2025
Q1 		$4.55M Sell
14,604
-606
-4% -$179K 0.56% 50
2024
Q4 		$3.96M Buy
15,210
+189
+1% +$56.1K 0.5% 55
2024
Q3 		$4.53M Sell
15,021
-1,613
-10% -$528K 0.63% 40
2024
Q2 		$5.2M Buy
16,634
+845
+5% +$248K 0.77% 30
2024
Q1 		$4.49M Buy
15,789
+1,955
+14% +$572K 0.97% 27
2023
Q4 		$3.98M Buy
13,834
+2,750
+25% +$749K 0.97% 27
2023
Q3 		$2.89M Buy
11,084
+10,166
+1,107% +$2.54M 0.8% 32
2023
Q2 		$204K Sell
918
-39
-4% -$9.05K 0.06% 186
2023
Q1 		$231K Sell
957
-22
-2% -$5.4K 0.06% 175
2022
Q4 		$269K Sell
979
-16
-2% -$4.29K 0.08% 160
2022
Q3 		$230K Sell
995
-29
-3% -$7.03K 0.07% 167
2022
Q2 		$253K Sell
1,024
-23
-2% -$5.64K 0.08% 173
2022
Q1 		$262K Buy
1,047
+61
+6% +$14K 0.06% 198
2021
Q4 		$222K Sell
986
-111
-10% -$23.4K 0.05% 219
2021
Q3 		$229K Sell
1,097
-31
-3% -$7.13K 0.05% 204
2021
Q2 		$275K Sell
1,128
-3
-0.3% -$738 0.07% 186
2021
Q1 		$281K Sell
1,131
-28
-2% -$6.68K 0.08% 173
2020
Q4 		$271K Sell
1,159
-34
-3% -$7.84K 0.08% 168
2020
Q3 		$303K Sell
1,193
-52
-4% -$12.9K 0.11% 141
2020
Q2 		$319K Sell
1,245
-340
-21% -$77.6K 0.13% 134
2020
Q1 		$347K Buy
1,585
+235
+17% +$51.3K 0.18% 115
2019
Q4 		$325K Buy
1,350
+3
+0.2% +$661 0.13% 132
2019
Q3 		$265K Buy
1,347
+16
+1% +$3.07K 0.12% 137
2019
Q2 		$245K Hold
1,331
– – 0.11% 143
2019
Q1 		$253K Sell
1,331
-58
-4% -$11.1K 0.12% 139
2018
Q4 		$270K Buy
+1,389
New +$271K 0.16% 123

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Trivium Point Advisory's AMGN Position: Q1 2026 in Review

Trivium Point Advisory reduced its Amgen (AMGN) stake by 17% in Q1 2026, selling an estimated $208K and leaving 2,876 shares worth $1.01M. The position accounts for 0.18% of the portfolio, ranked #129.

Trivium Point Advisory first reported a position in AMGN in Q4 2018 and has held it in 30 quarters since. The position peaked at $5.2M in Q2 2024. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Trivium Point Advisory held 2,876 shares of Amgen worth $1.01M as of Q1 2026.
  • Trivium Point Advisory sold 583 Amgen shares in Q1 2026, an estimated $208K.
  • Amgen made up 0.18% of Trivium Point Advisory's portfolio in Q1 2026, its #129 holding.
  • Trivium Point Advisory first reported a position in Amgen in Q4 2018 and has held it in 30 quarters since.
  • Trivium Point Advisory's Amgen position peaked at $5.2M in Q2 2024.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Trivium Point Advisory's 13F filing for Q1 2026, filed 21 Apr 2026.